Cite
MLA Citation
Caroline C. Billingsley et al.. “Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy.” International journal of gynecological cancer, vol. 25, no. 7, n.d., pp. 1331–1336. http://access.bl.uk/ark:/81055/vdc_100137793032.0x00001e